Semler Scientific (NASDAQ:SMLR) Shares Gap Up – What’s Next?

Semler Scientific, Inc. (NASDAQ:SMLR)’s share price gapped up prior to trading on Monday . The stock had previously closed at $63.65, but opened at $66.95. Semler Scientific shares last traded at $72.79, with a volume of 568,868 shares changing hands.

Semler Scientific Price Performance

The business’s 50-day moving average price is $33.71 and its 200 day moving average price is $31.33. The firm has a market capitalization of $443.59 million, a price-to-earnings ratio of 29.78 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The firm had revenue of $13.51 million during the quarter.

Insider Buying and Selling at Semler Scientific

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total transaction of $283,500.00. Following the transaction, the chief executive officer now directly owns 60,220 shares of the company’s stock, valued at approximately $1,707,237. The trade was a 14.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 30.20% of the company’s stock.

Institutional Trading of Semler Scientific

A number of hedge funds and other institutional investors have recently bought and sold shares of SMLR. BOKF NA acquired a new stake in Semler Scientific during the 1st quarter worth about $227,000. Jacobs Levy Equity Management Inc. boosted its stake in shares of Semler Scientific by 20.6% during the first quarter. Jacobs Levy Equity Management Inc. now owns 98,252 shares of the company’s stock worth $2,870,000 after buying an additional 16,777 shares during the period. CWM LLC lifted its position in Semler Scientific by 486.3% in the second quarter. CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after purchasing an additional 744 shares during the period. Financial Strategies Group Inc. purchased a new position in Semler Scientific in the second quarter valued at about $263,000. Finally, Bank of New York Mellon Corp increased its stake in shares of Semler Scientific by 10.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company’s stock worth $709,000 after purchasing an additional 1,940 shares in the last quarter. Hedge funds and other institutional investors own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.